Conference Agenda
Our esteemed Advisory Board comprising leaders from biotech, pharma, VC, and academia is currently shaping the Longevity Biotech 2025 agenda
Submit the form to stay informed as speakers and sessions are announced.
Confirmed Speakers to Date
At Longevity Biotech 2025, we are assembling a world-class speaker faculty of researchers, drug developers, investors, and translational leaders advancing the science of aging. Early confirmed speakers include:
J. Scotch McClure
CEO & Chairman
Chief Scientific Officer
Lorna Harries
CEO
Robin Mansukhani
Raghav Sehgal
Principal Scientist
Adam Antebi
Director
Keith Comito
President
Anthony Sandrasagra
CSO
Chris Reading
SVP, Alzheimer’s Program
Benjamin LeCalvé
CEO
Michael Ringel
Chief Operating Officer
Elisabeth Roider
Founding Partner
Gil Blander
Founder
Patrick Burgermeister
Partner
Vera Gorbunova
Professor of Biology
Joan Mannick
CEO
Aurora Griffin
Managing Partner Investor Relations Lead
Sebastian Brunemeier
Co-Founder & General Partner
Nina Horowtiz
CEO
Sessions
The Fundamental Biology of Aging
Preclinical Discovery & Mechanistic Insights
Drug Repurposing & Adjacent Therapeutics
Clinical Trials & Readouts
Regulatory Landscape
Market Landscape & Investment Strategy
